SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $82.56 | 52-week high | $105.47 |
| Prev. close | $82.48 | 52-week low | $66.66 |
| Day low | $81.42 | Volume | 8,086,600 |
| Day high | $83.33 | Avg. volume | 10,887,319 |
| 50-day MA | $78.93 | Dividend yield | 0.17% |
| 200-day MA | $90.85 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Biotech |
| Assets Under Management (AUM) | 5.07M |
| Net Asset Value (NAV) | $82.48 |
| Options? | Yes |
| Total Holdings | 130 |
XBI Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
XBI Top Holdings
| Symbol | Company | % of Total |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 3.2% |
| EXAS | EXACT SCIENCES CORP | 3.02% |
| BPMC | BLUEPRINT MEDICINES CORP | 2.99% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.92% |
| NTRA | NATERA INC | 2.83% |
| UTHR | UNITED THERAPEUTICS CORP | 2.69% |
| INCY | INCYTE CORP | 2.53% |
| INSM | INSMED INC | 2.52% |
| GILD | GILEAD SCIENCES INC | 2.45% |
| BIIB | BIOGEN INC | 2.4% |
XBI Price Returns
| 1-mo | 6.74% |
| 3-mo | -5.42% |
| 6-mo | -16.72% |
| 1-year | -10.92% |
| 3-year | 13.91% |
| 5-year | -19.45% |
| YTD | -8.32% |
| 2024 | 1.01% |
| 2023 | 7.60% |
| 2022 | -25.87% |
| 2021 | -20.45% |
| 2020 | 48.33% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||